Acne Shave — Class II drug recall D-0860-2018
Terminated recall by Shadow Holdings DBA Bocchi Labs, reported 2018-06-20, distributed nationwide. CGMP Deviations: products may be contaminated with bacteria.
| Recall number | D-0860-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Shadow Holdings DBA Bocchi Labs, Santa Clarita, CA, United States |
| Recall initiated | 2018-05-25 |
| Classified | 2018-06-12 |
| Reported by FDA | 2018-06-20 |
| Terminated | 2019-08-13 |
| Distributed | Nationwide (US) |
| Quantity | 8,208 tubes |
| Reason classes | microbial contamination, cgmp |
| UPC / GTIN / UDI-DI | 00780707731116 |
Product
Acne Shave (salicylic acid) Shave Cream Acne Shield, 0.5%, 5.1 FL OZ (150 mL) tube, Distributed by: United Exchange Corp., 17311 Valley View Blvd, Cerritos, CA 90703 USA, UPC 7 80707 73111 6.
Reason for recall
CGMP Deviations: products may be contaminated with bacteria.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0860-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.